JANIS ALEXANDER: Open Payments
NPI 1457593337 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,338 in 141 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,101 · 2025 $2,338
Food & beverage: $2,254Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $551 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $296 |
| Gilead Sciences, Inc. | 12 | $263 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $232 |
| Janssen Biotech, Inc. | 10 | $200 |
| Madrigal Pharmaceuticals | 10 | $190 |
| Ardelyx, Inc. | 6 | $184 |
| Aimmune Therapeutics, Inc. | 7 | $122 |
| Phathom Pharmaceuticals, Inc. | 14 | $110 |
| QOL Medical, LLC | 3 | $101 |
Products named: ENTYVIO, XIFAXAN, TREMFYA, REZDIFFRA, IBSRELA, RINVOQ, LINZESS, Livdelzi.
Industry payments across TX — which companies pay providers there.
